You just read:

Spherix Inc. Announces Definitive Terms Reached to Acquire Controlling Interest in Hoth Therapeutics, a Biopharmaceutical Company Developing its BioLexa Platform to Treat Skin Illness Such as Eczema.

News provided by

Spherix Incorporated

Jun 20, 2017, 08:00 ET